EntrepreneurialCheck

Reshape Biotech valuation

The estimated Reshape Biotech valuation is $200.0M. This Reshape Biotech valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: Carl-Emil Grøn Fuglesang net worth, Daniel Storgaard net worth, and Magnus Nyborg Madsen net worth.

Carl-Emil Grøn Fuglesang
Founder
$18.67M
Daniel Storgaard
Founder
$18.67M
Magnus Nyborg Madsen
Founder
$18.67M

Search this company in the directory

FAQ: Reshape Biotech valuation and founders net worth

What is Reshape Biotech's valuation?

The estimated Reshape Biotech valuation is $200.0M. This Reshape Biotech valuation is an independent model output, not a verified appraisal, official mark, or financial advice.

How much did Reshape Biotech raise?

Reshape Biotech raised $20.0M in disclosed funding. How much Reshape Biotech raised informs the estimated Reshape Biotech valuation on this hub. Independent estimate only — not a complete financing history or financial advice.

Who founded Reshape Biotech?

Carl-Emil Grøn Fuglesang, Daniel Storgaard, and Magnus Nyborg Madsen founded Reshape Biotech. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.